B Lynne Parshall Ionis Pharmaceuticals Inc (IONS) insider trading activity

B Lynne Parshall is Director of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 87,265 shares of IONS, which is worth approximately $3.31 Million. The most recent transaction as insider was on Jul 15, 2024, when has been sold 4,677 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.3K

5.66% 3M change

5.66% 12M change

Total Value Held $3.31 Million

B LYNNE PARSHALL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2024	BUY Exercise of conversion of derivative security	-	4,677 Added 5.09%	87,265 Common Stock
Dec 28 2023	SELL Open market or private sale	$2,134,329 $50.19 p/Share	42,525 Reduced 33.99%	82,588 Common Stock
Dec 28 2023	BUY Exercise of conversion of derivative security	$2,013,133 $47.34 p/Share	42,525 Added 25.37%	125,113 Common Stock
Dec 27 2023	SELL Open market or private sale	$2,511,500 $50.23 p/Share	50,000 Reduced 37.71%	82,588 Common Stock
Dec 27 2023	BUY Exercise of conversion of derivative security	$2,367,000 $47.34 p/Share	50,000 Added 27.38%	132,588 Common Stock
Dec 26 2023	SELL Open market or private sale	$1,292,314 $51.46 p/Share	25,113 Reduced 23.32%	82,588 Common Stock
Dec 26 2023	BUY Exercise of conversion of derivative security	$1,188,849 $47.34 p/Share	25,113 Added 18.91%	107,701 Common Stock
Sep 26 2023	SELL Open market or private sale	$451,300 $45.13 p/Share	10,000 Reduced 10.8%	82,588 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	-	7,110 Added 7.13%	92,588 Common Stock
Jul 15 2022	BUY Exercise of conversion of derivative security	-	7,998 Added 8.56%	85,478 Common Stock
Jan 18 2022	SELL Payment of exercise price or tax liability	$49,758 $30.12 p/Share	1,652 Reduced 2.09%	77,480 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	-	5,754 Added 6.78%	79,132 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	-	8,000 Added 9.83%	73,378 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$167,968 $61.28 p/Share	2,741 Reduced 4.02%	65,378 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	-	10,655 Added 13.53%	68,119 Common Stock
Dec 23 2020	SELL Open market or private sale	$600,000 $60.0 p/Share	10,000 Reduced 14.82%	57,464 Common Stock
Nov 25 2020	SELL Open market or private sale	$179,679 $50.05 p/Share	3,590 Reduced 5.05%	67,464 Common Stock
Nov 25 2020	BUY Exercise of conversion of derivative security	$143,133 $39.87 p/Share	3,590 Added 4.81%	71,054 Common Stock
Nov 24 2020	SELL Open market or private sale	$36,082 $50.82 p/Share	710 Reduced 1.04%	67,464 Common Stock
Nov 24 2020	BUY Exercise of conversion of derivative security	$28,308 $39.87 p/Share	710 Added 1.03%	68,174 Common Stock
Nov 23 2020	SELL Open market or private sale	$160,384 $50.12 p/Share	3,200 Reduced 4.53%	67,464 Common Stock
Nov 23 2020	BUY Exercise of conversion of derivative security	$127,584 $39.87 p/Share	3,200 Added 4.33%	70,664 Common Stock

Also insider at

CYTK

CYTOKINETICS INC Healthcare

Director

FHTX

Foghorn Therapeutics Inc. Healthcare

BLP

B Lynne Parshall

Director

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account